Literature DB >> 7054049

Evidence that hepatic crystalline deposits in a patient with protoporphyria are composed of protoporphyrin.

J R Bloomer, R Enriquez.   

Abstract

The livers of patients with protoporphyria and hepatic disease typically contain pigment crystals which may be a factor in the pathogenesis of liver injury. We isolated and characterized these crystals from a patient who developed hepatic failure and underwent liver transplantation. The prophyrin concentration in the liver was 516 micrograms/g wet weight (normal is a trace amount), over 99% of which was protoporphyrin. Through a discontinuous sucrose density gradient, followed by tissue digestion with deoxycholate, pigment crystals were obtained that had ultrastructural features like those in the whole liver section. After the crystals were dissolved in perchloric acid-methanol, their fluorescence emission and excitation spectra were identical to those of an extract of whole liver tissue and to a protoporphyrin standard. This provides evidence that the pigment crystals in livers of patients with protoporphyria and hepatic disease are composed of protoporphyrin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054049

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  5 in total

Review 1.  Heme biosynthesis and the porphyrias.

Authors:  John D Phillips
Journal:  Mol Genet Metab       Date:  2019-04-22       Impact factor: 4.797

Review 2.  Bile formation and secretion.

Authors:  James L Boyer
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

3.  Protoporphyrin overload in unrestrained rats: biochemical and histopathologic characterization of a new model of protoporphyric hepatopathy.

Authors:  M M Berenson; R Kimura; W Samowitz; D Bjorkman
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

Review 4.  Protoporphyrin IX: the Good, the Bad, and the Ugly.

Authors:  Madhav Sachar; Karl E Anderson; Xiaochao Ma
Journal:  J Pharmacol Exp Ther       Date:  2015-11-20       Impact factor: 4.030

5.  Hepatic protoporphyrin metabolism in patients with advanced protoporphyric liver disease.

Authors:  J R Bloomer
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.